Cancer Res (2022) 82 (22_Supplement): PR006.

Abstract. Despite availability of new therapies, outcomes for patients with relapsed metastatic breast cancer is poor with moderate median overall survival. High CXCR4 levels correlate with aggressive ...

Cancer Res (2024) 84 (7_Supplement): LB055.

1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...

1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...

Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.

1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.

1AstraZeneca, ICC, Early Oncology, R&D, Cambridge, United Kingdom.

1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

1Yonsei University, College of Medicine, Seoul, Republic of Korea.

Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), ...